BioArctic AB (publ) (STO:BIOA B) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Sep 01
Have your own idea? Try our Stock Screener
Markets has moved to Discover
You can now access Markets by navigating to Discover and selecting Markets.
Swedish (OMX) Biotech Industry Analysis
UpdatedSep 09, 2024
DataAggregated Company Financials
Companies66
- 7D-1.3%
- 3M10.6%
- 1Y28.1%
- YTD11.4%
Over the last 7 days, the Biotech industry has dropped 2.0%, driven by Swedish Orphan Biovitrum declining 3.8%. Meanwhile, BioArctic actually outperformed within the industry, gaining 9.3% in the last week. In the past year, the industry has gained 29%. Looking forward, earnings are forecast to grow by 47% annually.
Industry Valuation and Performance
Has the Swedish Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 09 Sep 2024 | SEK 212.4b | SEK 31.5b | -SEK 5,570,575,522.59 | 49.2x | -38.1x | 6.8x |
| Wed, 07 Aug 2024 | SEK 187.9b | SEK 31.4b | -SEK 5,419,855,742.00 | 41.6x | -34.7x | 6x |
| Fri, 05 Jul 2024 | SEK 192.8b | SEK 30.6b | -SEK 5,537,890,608.79 | 38.6x | -34.8x | 6.3x |
| Sun, 02 Jun 2024 | SEK 198.9b | SEK 30.6b | -SEK 5,722,606,652.25 | 39.8x | -34.8x | 6.5x |
| Tue, 30 Apr 2024 | SEK 185.1b | SEK 30.8b | -SEK 5,567,617,777.93 | 50.4x | -33.2x | 6x |
| Thu, 28 Mar 2024 | SEK 187.4b | SEK 29.8b | -SEK 5,637,786,411.12 | 60x | -33.2x | 6.3x |
| Sat, 24 Feb 2024 | SEK 179.4b | SEK 29.8b | -SEK 5,694,219,485.91 | 51.4x | -31.5x | 6x |
| Mon, 22 Jan 2024 | SEK 186.9b | SEK 28.7b | -SEK 1,200,602,862.00 | 57.4x | -155.6x | 6.5x |
| Wed, 20 Dec 2023 | SEK 179.3b | SEK 28.7b | -SEK 1,169,872,731.00 | 60.2x | -153.3x | 6.2x |
| Fri, 17 Nov 2023 | SEK 166.4b | SEK 28.7b | -SEK 1,231,342,852.00 | 51.1x | -135.1x | 5.8x |
| Sun, 15 Oct 2023 | SEK 154.5b | SEK 27.4b | -SEK 1,963,051,432.00 | 48.8x | -78.7x | 5.6x |
| Tue, 12 Sep 2023 | SEK 152.0b | SEK 27.4b | -SEK 1,977,389,012.00 | 46.8x | -76.9x | 5.6x |
| Thu, 10 Aug 2023 | SEK 157.2b | SEK 27.5b | -SEK 1,576,085,928.00 | 53.6x | -99.7x | 5.7x |
| Sat, 08 Jul 2023 | SEK 160.7b | SEK 26.4b | -SEK 1,314,450,404.00 | 44.8x | -122.3x | 6.1x |
| Mon, 05 Jun 2023 | SEK 167.9b | SEK 26.4b | -SEK 1,190,026,092.00 | 45.5x | -141.1x | 6.4x |
| Wed, 03 May 2023 | SEK 177.1b | SEK 26.3b | -SEK 1,249,194,561.00 | 46.1x | -141.7x | 6.7x |
| Fri, 31 Mar 2023 | SEK 168.0b | SEK 25.4b | -SEK 2,118,153,927.00 | 41.9x | -79.3x | 6.6x |
| Sun, 26 Feb 2023 | SEK 170.0b | SEK 25.4b | -SEK 2,036,417,969.00 | 39.6x | -83.5x | 6.7x |
| Tue, 24 Jan 2023 | SEK 177.1b | SEK 23.8b | -SEK 1,838,625,977.00 | 32.3x | -96.3x | 7.4x |
| Thu, 22 Dec 2022 | SEK 159.7b | SEK 23.8b | -SEK 1,838,756,322.00 | 31.7x | -86.8x | 6.7x |
| Sat, 19 Nov 2022 | SEK 156.9b | SEK 23.9b | -SEK 1,720,558,502.00 | 32.1x | -91.2x | 6.6x |
| Mon, 17 Oct 2022 | SEK 153.0b | SEK 22.9b | -SEK 3,333,771,163.00 | 31.2x | -45.9x | 6.7x |
| Wed, 14 Sep 2022 | SEK 158.7b | SEK 22.9b | -SEK 3,245,854,870.00 | 33.9x | -48.9x | 6.9x |
| Fri, 12 Aug 2022 | SEK 173.3b | SEK 22.7b | -SEK 3,505,424,214.00 | 35.2x | -49.4x | 7.6x |
| Sun, 10 Jul 2022 | SEK 164.2b | SEK 21.4b | -SEK 3,520,210,178.00 | 40.3x | -46.7x | 7.7x |
| Tue, 07 Jun 2022 | SEK 158.9b | SEK 21.4b | -SEK 3,525,315,082.00 | 44.4x | -45.1x | 7.4x |
| Thu, 05 May 2022 | SEK 149.3b | SEK 21.3b | -SEK 3,496,410,527.00 | 45.9x | -42.7x | 7x |
| Sat, 02 Apr 2022 | SEK 175.9b | SEK 19.7b | -SEK 3,159,476,364.00 | 51.5x | -55.7x | 8.9x |
| Mon, 28 Feb 2022 | SEK 159.5b | SEK 19.6b | -SEK 2,900,436,904.00 | 49.6x | -55x | 8.1x |
| Wed, 26 Jan 2022 | SEK 159.5b | SEK 19.1b | -SEK 2,049,564,151.00 | 48.3x | -77.8x | 8.3x |
| Fri, 24 Dec 2021 | SEK 198.8b | SEK 19.1b | -SEK 2,003,890,102.00 | 52x | -99.2x | 10.4x |
| Sun, 21 Nov 2021 | SEK 204.4b | SEK 19.0b | -SEK 1,490,007,893.00 | 55.8x | -137.2x | 10.8x |
| Tue, 19 Oct 2021 | SEK 200.6b | SEK 18.1b | -SEK 1,346,004,827.00 | 47.4x | -149x | 11.1x |
| Thu, 16 Sep 2021 | SEK 217.8b | SEK 18.1b | -SEK 1,339,275,285.95 | 52.4x | -162.6x | 12x |
Price to Earnings Ratio
-162.6x
Current Industry PE
- Investors are relatively neutral on the Swedish Biotechs industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 7.2x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 20% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Trends
Which industries have driven the changes within the Swedish Healthcare industry?
| SE Market | -3.72% | |
| Healthcare | -1.00% | |
| Biotech | -1.25% | |
| Biotech | -1.25% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BIOA B BioArctic | SEK 182.00 | 10.9% +SEK 1.6b | -40.6% | PS53.7x | |
| VITR Vitrolife | SEK 253.00 | 1.1% +SEK 379.1m | 88.8% | PS9.7x | |
| SANION Saniona | SEK 5.22 | 20.0% +SEK 96.8m | -19.7% | PS23.3x | |
| MODTX Modus Therapeutics Holding | SEK 2.30 | 35.7% +SEK 21.7m | 14.4% | PB8.4x | |
| NXTCL NextCell Pharma | SEK 1.56 | 21.9% +SEK 20.5m | -53.7% | PS8.4x |
